Data gathered: February 1
Alternative Data for Lexeo Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 169 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 85 | Sign up | Sign up | Sign up |
About Lexeo Therapeutics
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases.
| Price | $5.43 |
| Target Price | Sign up |
| Volume | 142,680 |
| Market Cap | $254M |
| Year Range | $4.88 - $18.76 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Lexeo Therapeutics (NASDAQ:LXEO) Given “Outperform” Rating at Royal Bank of CanadaJanuary 22 - ETF Daily News |
 |
Analysts Set Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Target Price at $23.80January 19 - ETF Daily News |
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7 - GlobeNewswire |
|
|
Head-To-Head Analysis: AlloVir (NASDAQ:ALVR) & Lexeo Therapeutics (NASDAQ:LXEO)January 2 - ETF Daily News |
|
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Rating of “Buy” by AnalystsDecember 22 - ETF Daily News |
|
Wellington Management Group LLP Increases Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO)December 21 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 8.2M | -8.2M | -29M | -31M | -0.892 |
| Q2 '24 | 0 | 7.1M | -7.1M | -21M | -23M | -0.640 |
| Q1 '24 | 0 | 7.6M | -7.7M | -22M | -23M | -0.770 |
| Q4 '23 | 0 | 6.8M | -6.9M | -14M | -15M | -0.850 |
| Q3 '23 | 0 | 3.1M | -3.2M | -20M | -20M | -12.360 |
Insider Transactions View All
| Townsend Richard Nolan filed to sell 120,695 shares at $8.2. December 12 '24 |
| CHOLMONDELEY PAULA H filed to buy 30,627 shares at $7. November 26 '24 |
| Townsend Richard Nolan filed to sell 120,695 shares at $7.8. November 13 '24 |
| Townsend Richard Nolan filed to sell 120,695 shares at $8.1. October 15 '24 |
| Townsend Richard Nolan filed to sell 120,695 shares at $10.7. September 11 '24 |
Similar companies
Read more about Lexeo Therapeutics (LXEO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Lexeo Therapeutics?
The Market Cap of Lexeo Therapeutics is $254M.
What is the current stock price of Lexeo Therapeutics?
Currently, the price of one share of Lexeo Therapeutics stock is $5.43.
How can I analyze the LXEO stock price chart for investment decisions?
The LXEO stock price chart above provides a comprehensive visual representation of Lexeo Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Lexeo Therapeutics shares. Our platform offers an up-to-date LXEO stock price chart, along with technical data analysis and alternative data insights.
Does LXEO offer dividends to its shareholders?
As of our latest update, Lexeo Therapeutics (LXEO) does not offer dividends to its shareholders. Investors interested in Lexeo Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Lexeo Therapeutics?
Some of the similar stocks of Lexeo Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.